Table 1.
Variables | PLWH without MetS | PLWH with MetS | pvalue |
---|---|---|---|
Sample (n) | 100 | 100 | |
Sex, Male, n (%) | 90 (90.0) | 90 (90.0) | 1.00** |
Age, mean (sd) | 54.4 (9.5) | 54.6 (8.5) | 0.80* |
Ethnicity, n (%) | 0.87** | ||
Caucasian | 88 (88.0) | 86 (86.0) | |
Asian | 3 (3.0) | 2 (2.0) | |
Black | 4 (4.0) | 6 (6.0) | |
Other/unknown | 5 (5.0) | 6 (6.0) | |
Immunodeficiency, n (%) | 14 (14.0) | 13 (13.0) | 1.00** |
Exposure to early-generation ART, n (%) | 34 (34.0) | 46 (46.0) | 0.11** |
VAT, mean (sd) | 76.1 (53.6) | 149.4 (71) | < 0.001* |
SAT, mean (sd) | 111.1 (71.1) | 150.6 (77.1) | < 0.001* |
ART_NRTI, n (%) | 95 (95.0) | 96 (96.0) | 1.00** |
ART_NNRTI, n (%) | 54 (54.0) | 45 (45.0) | 0.26** |
ART_PI, n (%) | 37 (37.0) | 47 (47.0) | 0.20** |
ART_INSTI, n (%) | 16 (16.0) | 21 (21.0) | 0.47** |
ART_other/unknown, n (%) | 0 (0.0) | 3 (3.0) | 0.24* |
*Mann-Whitney U test and **Chi-square test.
P-values in bold indicates a significant difference in the concerned variables between the two groups. Immunodeficiency was defined as the lowest CD4+ T-cell count <200 cells/µl or previous AIDS condition and exposure to early-generation ART was defined as patients medicated with thymidine analogues, didanosine and/or indinavir.